Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,205.00
Bid: 2,208.00
Ask: 2,210.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.09%)
Open: 2,195.00
High: 2,211.00
Low: 2,158.00
Yest. Close: 2,193.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

Broker tips: Tesco, Burberry, Hikma

Panmure Gordon has maintained its 'buy' rating and 440p target price for supermarket group Tesco, highlighting a 'welcome shift in strategy' following the firm's full-year results. Panmure reckons that Tesco is on track in the UK and expects the recovery to "slowly emerge" this year and said that i

17 Apr 13 11:24

Broker snap: Jefferies cuts target for Hikma but stays upbeat

Jefferies has cut its price target for pharmaceuticals firm Hikma from 1,150p to 1,040p after the company's decision to hold on to its global injectables business. Hikma said on Wednesday that it has seen a "significant amount of interest" in the injectables business by third parties. However, the

17 Apr 13 11:16

Hikma Pharmaceuticals decides not to sell Injectables business

FTSE 250-listed company Hikma Pharmaceuticals has announced that following the conclusion of its strategic review of its global Injectables business, it has decided that the business should remain part of the Hikma Group. The reason behind the decision is that it sees the business as holding a uni

17 Apr 13 08:37

Wednesday broker round-up UPDATE

African Barrick Gold: Deutsche Bank cuts target price from 230p to 173p, while its hold recommendation is reiterated. Ashmore Group: Morgan Stanley raises target price from 395p to 444p and maintains an equal-weight rating. Ashtead Group: Jefferies increases target price from 615p to 690o and reit

17 Apr 13 07:20

Ex-divs to take 5.5 points off FTSE 100 on April 17

LONDON, April 15 (Reuters) - The following FTSE 100 companies will go ex-dividend on Wednesday, after which investors will no longer qualify for the latest dividend payout. According to Reuters calculations at current market prices, the effect of the resulting adjustment to prices by marke

15 Apr 13 09:37

Thursday broker round-up UPDATE

Amara Mining: After having been under review, Cantor Fitzgerald reinitiates coverage with a price target of 81p and a buy recommendation. Antofagasta: Citigroup shifts target price from 990p to 1000p, but retains its sell recommendation. Ashtead Group: Investec raises target price from 475p to 700

14 Mar 13 07:11

London open: Ex-div stocks weigh on FTSE 100 early on

Traders chose to take profits on Wednesday morning, taking advantage of the strong gains seen in previous sessions, with the FTSE 100 pulling back sharply from five-year highs. So far this year, the index has gained nearly 10% and is trading near levels not seen since late 2007. According to Reute

13 Mar 13 08:33

Revenue growth at Hikma to slow down after strong year

Pharmaceuticals group Hikma registered an impressive increase in revenue in 2012, helped by strong performances from both the Branded and Injectables divisions, but warned that sales growth would slow this year. After the 20.8% growth seen in 2012, the company said that the rate would reduce to ar

13 Mar 13 07:19

Monday broker round-up UPDATE

Aggreko: JP Morgan takes target price from 1845p to 1870p, while reiterating a neutral rating. Anglo American: Nomura reduces target price from 1800p to 1700p and downgrades from neutral to reduce. ARM Holdings: Deutsche Bank increases target price from 400p to 445p, but still recommends selling.

4 Mar 13 07:12

London close: Strong US data prompts late rally...again

For a third day in a row, the FTSE 100 index rallied in afternoon trade on the back of strong economic figures from America, as investors temporarily shrugged off concerns about the automatic spending cuts which kick in later today. US President Barack Obama met with congressional leaders this afte

1 Mar 13 17:13

FTSE 250 movers: Hikma soars on 'unsolicited enquiries'

Hikma Pharmaceuticals on Friday confirmed that it has received several unsolicited enquiries in its Injectables business and is now undertaking a review of strategic options for its future, prompting a strong rise in the share price. High Street betting shop William Hill jumped after announcing th

1 Mar 13 15:23

Hikma Pharma shares rise on 'unsolicited enquiries'

Hikma Pharmaceuticals on Friday confirmed that it has received several unsolicited enquiries in its Injectables business and is now undertaking a review of strategic options for its future. In a statment the group's Chief Executive Officer said: "We have received a number of unsolicited expression

1 Mar 13 11:42

Thursday broker round-up UPDATE

AZ Electronic Materials: Goldman Sachs moves target price from 440p to 450p and retains a buy recommendation. Bovis Homes Group: Deutsche Bank shifts target price from 667p to 679p, while downgrading to hold. British American Tabacco: Investec places its target price (previously 3350p) and buy rec

28 Feb 13 07:19

Thursday broker round-up UPDATE

African Barrick Gold: Deutsche Bank cuts target price from 410p to 340p, while staying with its hold recommendation. Investec reduces target price from 405p to 315p and downgrades from buy to hold. JP Morgan lowers target price from 370p to 290p and downgrades to underweight. AG Barr: Barclays down

14 Feb 13 08:09

Hikma signs agreement with EffRx for licensing of osteoporosis treatment Binesto

FTSE 250-listed pharmaceuticals group Hikma Pharmaceuticals has signed an agreement with EffRx for the licensing and distribution of osteoporosis treatment Binosto. The treatment, which is to be distributed throughout the Middle East and North Africa (MENA), represents the only buffered solution f

4 Feb 13 10:37

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.